Tema Oncology ETF (CANC) Holdings $25.39 -0.25 (-0.98%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Top 50 CANC HoldingsRankCompanyCurrent PriceWeightShares Held1AstraZeneca PLCN/A5.84%25,8592LLYEli Lilly and Company$929.79+1.0%5.48%4,1803BBIOBridgeBio Pharma$34.02-2.5%4.33%91,2704RVMDRevolution Medicines$39.81-2.3%4.09%65,9185MRKMerck & Co., Inc.$92.15-0.1%4.03%31,7926RHHBYRoche$41.74+0.7%3.94%63,5207BMYBristol-Myers Squibb$59.56-0.1%3.83%45,5258GMABGenmab A/S$23.05+1.6%3.75%119,2079EXELExelixis$39.00+0.8%3.68%70,96010Novartis AGN/A3.60%22,120 Get the Latest News and Ratings for CANC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. 11ONCBeigene$245.52-9.7%3.50%10,31612AMGNAmgen$310.75+0.9%3.20%7,16013Chugai Pharmaceutical Co., Ltd.N/A3.19%44,65814NUVLNuvalent$73.19-2.4%3.19%26,21915SMMTSummit Therapeutics$20.20-2.4%2.87%87,45216LEGNLegend Biotech$33.88-3.2%2.82%51,61817Daiichi Sankyo Company, LimitedN/A2.64%71,89618DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A2.27%586,327,06719GILDGilead Sciences$115.96+1.4%2.20%13,83120ABBVAbbVie$210.99+0.9%2.15%7,39721ARGXargenx$633.81+1.5%1.98%2,02022MRUSMerus$45.86-2.6%1.96%32,33523DAWNDay One Biopharmaceuticals$8.78-3.1%1.76%95,64324First American Treasury Obligations FundN/A1.66%1,102,44625ACLXArcellx$63.98-1.3%1.55%16,15826JANXJanux Therapeutics$32.39-1.5%1.48%26,46427IDYAIDEAYA Biosciences$20.04-2.6%1.47%47,01528BPMCBlueprint Medicines$91.73-5.0%1.46%10,23729MREOMereo BioPharma Group$2.38-1.0%1.13%261,68130SWTXSpringWorks Therapeutics$54.23-6.1%1.13%12,85931GHGuardant Health$43.22+1.6%1.10%15,54132REGNRegeneron Pharmaceuticals$687.99-1.5%1.10%1,08433INCYIncyte$71.36-2.9%1.06%10,07534LNTHLantheus$95.43+1.7%1.05%8,49635ARVNArvinas$17.22-2.7%0.96%35,96936CGONCG Oncology$25.20-2.6%0.96%22,30237SDGRSchrödinger$22.10-1.0%0.93%25,42938EXASExact Sciences$48.82+3.0%0.90%11,79339COGTCogent Biosciences$7.23-4.1%0.87%71,02540NRIXNurix Therapeutics$14.77-4.4%0.81%30,793Elon Musk Wants to Audit Fort Knox—What It Means for Your Retirement (Ad)You can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FREE. All you need is to know these 2 "magic words" only revealed inside your FREE copy of this 2025 Gold Guide.Tap the link to get your free 2025 Gold Guide now41ILMNIllumina$87.22-1.7%0.78%5,12042AGIOAgios Pharmaceuticals$33.61-5.4%0.77%15,47443ZYMEZymeworks$12.96-3.3%0.72%32,75344IMCRImmunocore$28.87-1.7%0.68%15,31245RCUSArcus Biosciences$10.50-3.6%0.58%30,39846CGEMCullinan Therapeutics$8.44-0.6%0.56%38,87047RLAYRelay Therapeutics$3.14-8.1%0.53%88,44048ORICORIC Pharmaceuticals$7.86-2.1%0.50%40,62849AUTLAutolus Therapeutics$1.72-0.9%0.32%109,59850CELCCelcuity$9.46+0.3%0.29%15,503 Geographic ExposureUnited States81.3%Japan6.2%United Kingdom5.9%Switzerland3.9%Netherlands2.6%Currency ExposureUSD83.9%JPY6.2%GBP5.9%CHF3.9%Sector ExposureHealth Care71.7%Consumer Discretionary0.6%Industry ExposureBiotechnology65.7%Pharmaceuticals3.9%Health Care Equipment & Supplies1.9%Diversified Consumer Services0.9%SubIndustry ExposureBiotechnology54.5%Pharmaceuticals9.2%Life Sciences Tools & Services1.1%Health Care Equipment0.8%Coupon Exposure4-60.5%Maturity Exposure15-200.5% Related Companies and Tools Related Companies YieldMax Crypto Industry and Tech Portfolio Option Income ETF Portfolio Companies Global X Genomics & Biotechnology ETF Portfolio Companies VictoryShares THB Mid Cap ESG ETF Portfolio Companies Procure Space ETF Portfolio Companies Tema Cardiovascular and Metabolics ETF Portfolio Companies Global X U.S. Electrification ETF Portfolio Companies Global X Data Center & Digital Infrastructure ETF Portfolio Companies Fidelity Disruptive Communications ETF Portfolio Companies Global X Aging Population ETF Portfolio Companies Tradr 2X Long Innovation ETF Portfolio Companies This page (NASDAQ:CANC) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
